Exelixis



Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 22.24M 10.04M 2025-03
Agios Pharmaceuticals USD -105351000 18.32M 2025-03
Amgen USD 3.75B 42M 2025-03
AstraZeneca USD 5.08B 182M 2025-03
Bayer EUR 3.59B 1.92B 2025-03
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Cytokinetics USD -153331000 16.67M 2025-03
Eisai JPY 8.81B 28.8B 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Exelixis USD 194.2M 23.1M 2025-04
Genmab DKK 204M 2.03B 2025-03
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Incyte USD 222.66M 97.54M 2025-03
Ionis Pharmaceuticals USD -141463000 35.91M 2025-03
MacroGenics USD -50784000 106.81M 2024-12
Merck USD 7.74B 625M 2025-03
Moderna USD -924000000 69M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Sanofi EUR 563M 3.93B 2024-12
Takeda JPY 128.14B 126.45B 2025-03
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Xencor USD 7.14M 64.97M 2024-12



Exelixis - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.